Feinstein Institute Scientist Recognized for I... - CLL Support

CLL Support

22,366 members38,465 posts

Feinstein Institute Scientist Recognized for Innovative CLL Research

Cllcanada profile image
CllcanadaTop Poster CURE Hero
0 Replies

Feinstein Institute for Medical Research Instructor Shih-Shih Chen, PhD, is continuing the Institute's tradition of innovating the diagnosis and treatment of chronic lymphocytic leukemia (CLL) through the recognition of her research that identifies a potential new therapy target for CLL.

The award was presented at the recent International Workshop on Chronic Lymphocytic Leukemia (iwCLL) for her abstract titled: "IL-4R – IL-4 axis Disruption by Ibrutinib Therapy Contributes to the Greater Vulnerability of U-CLL Clones to Loss of Microenvironmental Input."

These latest findings join the contributions made by Feinstein Institute Professors Kanti R. Rai, MD, and Nicholas Chiorazzi, MD, who have long been at the forefront of diagnosis and care of patients with CLL.

prnewswire.com/news-release...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...

You may also like...

MRD assessment in CLL

larger role in treatment assessment of chronic lymphocytic leukemia (CLL). This topic is explored...

Research survey on CLL/SLL

with CLL/SLL • Have you been diagnosed with chronic lymphocytic leukemia or small lymphocytic...

Combination therapy for our CLL

combination treatment strategies for chronic lymphocytic leukemia (CLL). You can read my summary...

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

-btk-inhibitors-in-chronic-lymphocytic-leukemia-cll/ In my #7 of the top 10 CLL abstracts from ASH,

An Early Look at When CAR-T Therapy Fails Patients With CLL

com/home/cancer-topics/chronic-lymphocytic-leukemia/chronic-leukemia-cll-early-look-cart-therapy-pat